Stellar signs pact with SAFC
As per the agreement, Stellar will be responsible for producing KLH commercial intermediate and supplying all aquaculture-derived KLH intermediate required for production of SAFC cGMP KLH formulations. However,
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.